Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Revista Espanola De Salud Publica|August 31, 2021
[Methamphetamine use in chemsex and its consequences on mental health: a descriptive study.]Patricia Gavín, Néstor Arbelo, Miquel Monràs, et al.
Therapeutic Advances in Musculoskeletal Disease|December 6, 2021
Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort studyPatricia Bogas, Chamaida Plasencia-Rodriguez, Victoria Navarro-Compán, et al.
Scientific Reports|September 22, 2017
Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis PatientsCristina Regueiro, Laura Nuño, Ana M Ortiz, et al.
Rheumatology (Oxford, England)|December 5, 2025
Expanded blood PD-1hi Tfh cells in seropositive clinically suspect arthralgia predict progression to rheumatoid arthritisLaura Nuño, Beatriz Nieto-Carvalhal, Mariana Gutiérrez-Riart, et al.
RMD Open|September 29, 2023
Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatmentMarta Novella-Navarro, JoséLuis Cabrera-Alarcón, Natalia López-Juanes, et al.
Clinical and Experimental Rheumatology|April 4, 2020
Lower frequency of anti-citrullinated protein antibodies among early arthritis patients with high body mass indexPablo Moreno-Fresneda, Ana Triguero-Martínez, Israel Olivas-Martínez, et al.
Arthritis Research & Therapy|December 13, 2019
Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinicsCristina Regueiro, Lorena Rodríguez-Martínez, Laura Nuño, et al.
Clinical Rheumatology|November 8, 2018
The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitorsAna Martínez-Feito, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, et al.
Rheumatology (Oxford, England)|February 6, 2024
Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritisIrene Monjo-Henry, Mariela Uyaguari, Laura Nuño, et al.
Rheumatology (Oxford, England)|March 24, 2011
Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritisDora Pascual-Salcedo, Chamaida Plasencia, Susana Ramiro, et al.
Pageof 9